NFKB1 and lymphoma: Experimental data showed that HCV-induced lymphoma development may act through multistep processes involving a variety of oncogenic mechanisms, such as HCV-induced chronic B-cell immune stimulation, genetic damage, and dysregulation of signalling pathways (NF-kB, JNF, ERK and NOTCH signalling pathways) [43–48].